TipRanks
Sino-Life Group Limited (HK:8296)
:8296
Hong Kong Market
Want to see HK:8296 full AI Analyst Report?

Sino-Life Group Limited (8296) AI Stock Analysis

0 Followers

Top Page

HK:8296

Sino-Life Group Limited

(8296)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
HK$0.15
▼(-63.75% Downside)
Action:Reiterated
Date:09/17/26
The score is driven down primarily by weak financial performance (persistent losses, recent revenue contraction, and negative operating/free cash flow). Technical indicators also point to a sustained downtrend (below key moving averages with negative MACD and very weak RSI). Valuation does not provide a clear offset because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Stable balance sheet
The sizable equity base and moderate leverage provide a comparatively stable financial foundation. This can preserve flexibility to maintain operations and respond to business needs, although the benefit depends on the company reversing losses before capital is materially eroded over time.
Negative Factors
Persistent unprofitability
Recurring net losses and mostly negative EBIT show that gross profit has not translated into sustainable operating earnings. Continued unprofitability can erode the equity base, restrict internally funded investment, and make a durable improvement in financial performance dependent on a successful turnaround.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable balance sheet
The sizable equity base and moderate leverage provide a comparatively stable financial foundation. This can preserve flexibility to maintain operations and respond to business needs, although the benefit depends on the company reversing losses before capital is materially eroded over time.
Read all positive factors

Sino-Life Group Limited (8296) vs. iShares MSCI Hong Kong ETF (EWH)

Sino-Life Group Limited Business Overview & Revenue Model

Company Description
Sino-Life Group Limited, an investment holding company, provides funeral and related services in the People’s Republic of China, Taiwan, Hong Kong, and Vietnam. It operates in two segments, Funeral Services; and Biotechnical and other businesses. ...

Sino-Life Group Limited Financial Statement Overview

Summary
Financials are weak overall: the company has persistent net losses and mostly negative EBIT, plus operating cash flow and free cash flow turned negative in 2023–2025. The balance sheet is comparatively steadier with moderate leverage and improving debt-to-equity, but ongoing losses and recent revenue decline (~18% in 2025) keep the score low.
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
28
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue39.34M64.38M74.94M72.57M77.97M72.86M
Gross Profit14.02M30.95M32.28M33.48M39.80M37.98M
EBITDA-12.54M-8.02M-4.96M1.70M11.96M-4.28M
Net Income-16.47M-6.56M-8.70M-7.17M-847.00K-9.87M
Balance Sheet
Total Assets207.59M229.53M250.63M271.71M284.79M263.85M
Cash, Cash Equivalents and Short-Term Investments127.48M133.16M148.63M173.51M180.59M156.13M
Total Debt19.29M21.79M29.68M37.43M27.90M33.49M
Total Liabilities121.75M131.29M147.09M163.17M153.97M158.27M
Stockholders Equity109.17M120.42M123.45M123.72M113.22M114.61M
Cash Flow
Free Cash Flow-2.91M-6.22M-8.97M-3.04M7.77M-4.31M
Operating Cash Flow-2.91M-4.85M-8.21M-2.60M10.24M-407.00K
Investing Cash Flow2.77M2.08M-3.30M17.36M-32.20M-1.83M
Financing Cash Flow-2.09M-7.40M-2.10M-7.66M18.77M-7.75M

Sino-Life Group Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.40
Price Trends
50DMA
0.15
Positive
100DMA
0.19
Negative
200DMA
0.26
Negative
Market Momentum
MACD
<0.01
Negative
RSI
74.24
Negative
STOCH
18.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8296, the sentiment is Neutral. The current price of 0.4 is above the 20-day moving average (MA) of 0.15, above the 50-day MA of 0.15, and above the 200-day MA of 0.26, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 74.24 is Negative, neither overbought nor oversold. The STOCH value of 18.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8296.

Sino-Life Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
HK$1.53B8.4343.78%12.12%-14.68%-13.60%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
57
Neutral
HK$1.59B43.766.47%―2.78%-41.23%
56
Neutral
HK$6.03B14.096.50%20.98%――
54
Neutral
HK$228.80M-1.97-13.22%15.53%-16.99%-326.96%
50
Neutral
HK$73.26M-40.50-0.93%6.43%-2.31%66.07%
43
Neutral
HK$14.84M-0.63-17.95%―-26.00%-188.55%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8296
Sino-Life Group Limited
0.16
-0.22
-58.68%
HK:1448
Fu Shou Yuan International Group
2.64
-0.09
-3.16%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
<0.01
9.46%
HK:0922
Anxian Yuan China Holdings Limited
0.10
-0.05
-32.68%
HK:1830
Perfect Medical Health Management Limited
1.20
-0.07
-5.36%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.82
0.39
94.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 17, 2026